Cardiome Pharma Corporation (CRME) Dropped -5.22% or -0.12 To Price $2.2 On Monday


Cardiome Pharma Corporation (CRME) dropped -5.22% or -0.12 to $2.2. It is near 223830 shares traded, which is 82.3% compare to the average total volume 271981. The market cap of CRME is $76.17 million. The year to date change is 47.77%. The 52 week price range is from $1.29 to $4.84. Price of CRME have changed 21.47% during last week. It have changed 61.11% over last month, 47.77% over last 3 months, 7.91% over last 6 months and -22.67% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CRME is 1.58. It is -28.18% below current price. The 200-day Moving Averages for CRME is 2.33. It is 5.91% above current price. The 52-week High is 4.84. It is 120.00% from the current price. The 52-week Low is 1.29. It is -41.36% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CRME is 2.38 on 2018-03-15. Short % to float is 0.37%. There are some statistics of CRME. It is has market cap $76.17 million. The share outstanding is 34.64 million. The average volume is 271981. The revenue is 16.97M. The gross profit is 12.13M. The percent of top 15 Institution holding is 56.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CRME is -83.09%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CRME is -36.39%.


Tags:

Share this post